Sarah Alexandrou 34th Lorne Cancer Conference 2022

Abstracts this author is presenting:

• MKK7 loss drives resistance to combination endocrine therapy + CDK4/6 inhibition in ER+ breast cancer — Welcome Function and Poster Session 1